Liyong Zhong
-
- Pituitary Gland Disorders and Treatments 23
- Growth Hormone and Insulin-like Growth Factors 15
- Thyroid Disorders and Treatments 3
- Rehabilitation top 10%
-
- Acute Ischemic Stroke Management 3
-
- Glioma Diagnosis and Treatment 13
-
- Neuroblastoma Research and Treatments 2
-
- Testicular diseases and treatments 6
- Adrenal and Paraganglionic Tumors 3
- Partner nations
- ChinaUnited States
In The Last Decade
Liyong Zhong
33 papers receiving 472 citations
Peers
Comparison fields: 5 of 72
- Endocrinology, Diabetes and Metabolism 222
- Rehabilitation 47
- Epidemiology 201
- Genetics 49
- Neurology 31
Countries citing papers authored by Liyong Zhong
This map shows the geographic impact of Liyong Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyong Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyong Zhong more than expected).
Fields of papers citing papers by Liyong Zhong
This network shows the impact of papers produced by Liyong Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyong Zhong. The network helps show where Liyong Zhong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liyong Zhong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 10 | |
| 13 | 2020 | 5 | |
| 14 | 2019 | 18 | |
| 15 | 2019 | 26 | |
| 16 | 2019 | 15 | |
| 17 | 2016 | 36 | |
| 18 | 2016 | 5 | |
| 19 | 2015 | 1 | |
| 20 | 2015 | 6 |
About Liyong Zhong
Liyong Zhong is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Internal Medicine, having authored 39 papers that have together received 477 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (23 papers), Growth Hormone and Insulin-like Growth Factors (15 papers), Glioma Diagnosis and Treatment (13 papers), Testicular diseases and treatments (6 papers), Acute Ischemic Stroke Management (3 papers), Adrenal and Paraganglionic Tumors (3 papers), Thyroid Disorders and Treatments (3 papers) and Neuroblastoma Research and Treatments (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (222 citations), Rehabilitation (47 citations) and Epidemiology (201 citations). Liyong Zhong has collaborated with scholars based in China and United States. Frequent co-authors include Hongjuan Fang, Chunxue Wang, Yongjun Wang, Liping Liu, Huaguang Zheng, Hao Li, Xingquan Zhao, Qian Jia, Yuhao Zhou and Yu Yan. Their work appears in journals such as Stroke, Medicine and Molecular and Cellular Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.